The global hemostasis products market is estimated to grow at a significant CAGR during the forecast period. The key factor contributing to the growth of the global hemostasis products market includes the rising number of trauma and surgical cases and technological advancements in the market such as modified chitosan dressing, intranasal splint for nasal/sinus surgery, hemostatic foams for the treatment of nosebleed, and many more. Surgical cases are recognized by the World Health Organization (WHO), as inevitable to manage several health conditions, which include CVD, injuries, cancer, obstructed labor, birth defects, and other conditions. According to the Lancet Commission on Global Surgery, Global Surgery 2030, 28-32% of the global burden of disease can be attributed to surgically treatable conditions in 2014 and is expected to increase by 60% in 2030.

Free Sample Copy @ https://www.omrglobal.com/request-sample/hemostasis-products-market

Hemostasis is the process in which bleeding or hemorrhage is stopped from the blood vessels due to normal vasoconstriction, abnormal vasoconstriction or coagulation, or surgical means (ligation), using the combined activity of vascular factors, platelets, and plasma coagulation regulators. For this purpose, the hemostasis products are used as they aid to control bleeding during surgery or accidents or trauma and also acts as fresh frozen plasma. The COVID-19 pandemic affected the hemostasis products market including the drop in the emergency surgical procedures and reduction in the operations, additionally, the reduction in the non-essential surgeries such as plastic surgeries affected the growth of the market.

A Full Report of Global Hemostasis Products Market is Available at:
https://www.omrglobal.com/industry-reports/hemostasis-products-market

The key players contributing to the growth of the global hemostasis products market by adopting various strategies such as product launches and developments, mergers and acquisitions, partnerships, and agreements, include Abbott Laboratories, Baxter International, Inc., C. R. Bard, Inc. (BD), CSL Behring LLC, Dexur, Grifols, S.A., Johnson & Johnson, Medtronic plc, Pfizer, Inc., Tricol Biomedical, among others. For instance, AQUABRI is a surgical sealant for aortic procedures launched by the Terumo Corporation in February 2020. It acts by reacting with water in the plasma and forming an elastic layer that adheres to the tissues.

Global Hemostasis Products Market – Segmentation
By Product
Topical Hemostasis Product
Collagen
Oxidized Regenerated Cellulose
Gelatin
Polysaccharides
Others
Infusible Hemostasis Product
Fresh Frozen Plasma
Platelet Concentrate from Donor Blood
Factor VIII
Prothrombin Complex
Others
Advanced Hemostasis Product
Flowable Complex
Thrombin Complex
Fibrin Complex
Synthetic Sealants
Others
By Application
Trauma
Surgery
Hemophilia
Myocardial Infarction
Thrombosis
Others
By Distribution Channel
Hospital
Retail Pharmacy
Online
Others

Global Hemostasis Products Market – Segmentation by Region 
North America 
United States
Canada
Europe
Germany
United Kingdom
France
Spain
Italy
Rest of Europe
Asia-Pacific 
China
Japan
India
Rest of Asia-Pacific
Rest of the World

Company Profiles
Abbott Laboratories,
Baxter International Inc.
C. R. Bard Inc. (BD)
CSL Behring LLC
Dexur
Grifols
S.A.

For More Customized Data, Request for Report Customization @ https://www.omrglobal.com/report-customization/hemostasis-products-market

About Orion Market Research

Orion Market Research (OMR) is a market research and consulting company known for its crisp and concise reports. The company is equipped with an experienced team of analysts and consultants. OMR offers quality syndicated research reports, customized research reports, consulting and other research-based services.

Media Contact:

Company Name: Orion Market Research
Contact Person: Mr. Anurag Tiwari
Email: [email protected] 
Contact no: +91 780-304-0404